HHLR Advisors (Hillhouse) Q1 2026 13F: top 20 holdings and quarterly changes高瓴资本 Q1 2026 13F:前 20 大持仓与季度变化
HHLR Advisors (Hillhouse) 13F snapshot: Q1 2026
HHLR Advisors (Hillhouse)'s latest 13F shows about $1.66B of reported US-listed long equity/ETF positions across 34 names.
How to read it
Top 20 holdings
1. PDD (Pdd Holdings Inc): $425.6M, 25.7% of 13F, 4,165,029 shares
2. BABA (Alibaba Group Hldg Ltd): $307.8M, 18.6% of 13F, 2,453,657 shares
3. ONC (Beone Medicines Ltd): $307.2M, 18.6% of 13F, 1,034,306 shares
4. FUTU (Futu Hldgs Ltd): $194.1M, 11.7% of 13F, 1,419,483 shares
5. LEGN (Legend Biotech Corp): $108.3M, 6.5% of 13F, 5,984,550 shares
6. AVBP (Arrivent Biopharma Inc): $90.6M, 5.5% of 13F, 3,929,117 shares
7. BEKE (Ke Hldgs Inc): $63.4M, 3.8% of 13F, 4,236,278 shares
8. CWAN (Clearwater Analytics Hldgs I): $32.3M, 2.0% of 13F, 1,365,971 shares
9. CTKB (Cytek Biosciences Inc): $29.1M, 1.8% of 13F, 6,657,030 shares
10. MRVL (Marvell Technology Inc): $16.9M, 1.0% of 13F, 171,033 shares
11. YSG (Yatsen Hldg Ltd): $15.0M, 0.9% of 13F, 4,885,873 shares
12. MAZE (Maze Therapeutics Inc): $10.9M, 0.7% of 13F, 366,028 shares
13. CTNM (Contineum Therapeutics Inc): $8.7M, 0.5% of 13F, 669,337 shares
14. API (Agora Inc): $7.4M, 0.4% of 13F, 2,098,553 shares
15. BULL (Webull Corp): $7.2M, 0.4% of 13F, 1,500,000 shares
16. TSM (Taiwan Semiconductor Manufac): $5.2M, 0.3% of 13F, 15,520 shares
17. SGMT (Sagimet Biosciences Inc): $3.8M, 0.2% of 13F, 724,800 shares
18. TUYA (Tuya Inc): $3.6M, 0.2% of 13F, 1,564,400 shares
19. GE (Ge Aerospace): $2.8M, 0.2% of 13F, 10,043 shares
20. VIPS (Vipshop Hldgs Ltd): $2.0M, 0.1% of 13F, 124,700 shares
Major quarterly changes
New positions (9)
Increased (2)
Decreased (5)
Closed (6)
Note: 13F covers quarter-end US-listed long equity/ETF holdings only. It excludes shorts, derivatives, cash, and intra-quarter trading. Informational research only, not investment advice.
高瓴资本 13F 持仓快照:Q1 2026
高瓴资本 最新 13F 显示,2026 年第 1 季度披露的美股多头持仓市值约 $1.66B,覆盖 34 个标的。
怎么读
前 20 大持仓
1. PDD(拼多多):$425.6M,占 13F 25.7%,4,165,029 股
2. BABA(阿里巴巴):$307.8M,占 13F 18.6%,2,453,657 股
3. ONC(百济神州):$307.2M,占 13F 18.6%,1,034,306 股
4. FUTU(富途):$194.1M,占 13F 11.7%,1,419,483 股
5. LEGN(传奇生物):$108.3M,占 13F 6.5%,5,984,550 股
6. AVBP(Arrivent Biopharma Inc):$90.6M,占 13F 5.5%,3,929,117 股
7. BEKE(贝壳):$63.4M,占 13F 3.8%,4,236,278 股
8. CWAN(Clearwater Analytics Hldgs I):$32.3M,占 13F 2.0%,1,365,971 股
9. CTKB(Cytek Biosciences Inc):$29.1M,占 13F 1.8%,6,657,030 股
10. MRVL(迈威尔科技):$16.9M,占 13F 1.0%,171,033 股
11. YSG(广州逸仙电子商务有限公司):$15.0M,占 13F 0.9%,4,885,873 股
12. MAZE(Maze Therapeutics Inc):$10.9M,占 13F 0.7%,366,028 股
13. CTNM(Contineum Therapeutics Inc):$8.7M,占 13F 0.5%,669,337 股
14. API(Agora Inc):$7.4M,占 13F 0.4%,2,098,553 股
15. BULL(微牛):$7.2M,占 13F 0.4%,1,500,000 股
16. TSM(台积电):$5.2M,占 13F 0.3%,15,520 股
17. SGMT(Sagimet Biosciences Inc):$3.8M,占 13F 0.2%,724,800 股
18. TUYA(涂鸦智能):$3.6M,占 13F 0.2%,1,564,400 股
19. GE(通用电气):$2.8M,占 13F 0.2%,10,043 股
20. VIPS(唯品会):$2.0M,占 13F 0.1%,124,700 股
本季度主要变化
新建仓 (9)
加仓 (2)
减仓 (5)
清仓 (6)
说明:13F 只覆盖季度末美国上市股票/ETF 的多头仓位,不包括空头、衍生品、现金和季度内交易路径;本文用于研究参考,不构成投资建议。
This analysis was generated by InvestLog AI based on SEC filings, Form 4 insider transactions, Form 144 planned-sale notices, 13F institutional holdings, analyst ratings, and market data. It is for informational purposes only and does not constitute investment advice.这篇研究由 InvestLog AI 基于 SEC 披露、Form 4 内部人交易、Form 144 计划减持、13F 机构持仓、分析师评级和市场数据生成。内容仅供参考,不构成投资建议。